Hepatitis caused by antidepressive therapy with maprotiline and opipramol

Pharmacopsychiatry

Volumn 31, Issue 4, 1998, Pages 152-155

  Braun, J S ^a,d   Geiger, R ^b   Wehner, H ^c   Schaffer S ^a   Berger, M ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b Medical Clinic II   (Germany)

^c Institute of Pathology   (Germany)

^d ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; MAPROTILINE; MIRTAZAPINE; OPIPRAMOL;

ADULT; ARTICLE; CASE REPORT; HEPATITIS; HUMAN; LIVER BIOPSY; LIVER TOXICITY; MAJOR DEPRESSION; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SYMPTOM;

EID: 0031706560     PISSN: 01763679     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-979319     Document Type: Article

References (21)

1. Aleem, A., V. Lingam: Hepatotoxicity following treatment with maprotiline. J. Clin. Psychopharmacol. 7 (1987) 54-55
2. Blackwell, B.: Adverse effects of antidepressant drugs. Part 1: Monoamine oxidase inhibitors and tricyclics. Drugs 21 (1981) 201-219
3. Danan, G., J. Bernuau, X. Moullot, C. Degott, D. Pessayre: Amitriptyline-induced fulminant hepatitis. Digestion 30 (1984) 179-184
4. Davis, M.: Hepatotoxicity of antidepressants. Int. Clin. Psychopharmacol. 6 (1991) 97-103
5. Helmchen, C., R. J. Boerner, R. Meyendorf, U. Hegerl: Reversible hepatotoxicity of paroxetine in a patient with major depression. Pharmacopsychiatry 29 (1996) 223-226
6. Moldawsky, R. J.: Hepatotoxicity associated with maprotiline therapy: case report. J. Clin. Psychiatry 45 (1984) 178-179
7. Moskovitz, R., C. L. DeVane, R. Harris, R. B. Stewart: Toxic hepatitis and single daily dosage imipramine therapy. J. Clin. Psychiatry 43 (1982) 165-166
8. Pedersen, A. M., H. K. Enevoldsen: Nortriptyline-induced hepatic failure. Ther. Drug Monit. 18 (1996) 100-102
9. Pinder, R. M., R. N. Brogden, T. M. Speight, G. S. Avery: Maprotiline: A review of its pharmacological properties and therapeutic efficacy in mental depressive states. Drugs 13 (1977) 321-352
10. Powell Jr., W. J., J. Koch-Weser, R. A. Williams: Lethal hepatic necrosis after therapy with imipramine and desipramine. J. A. M. A. 206 (1968) 642-645
11. Price, L. H., J. C. Nelson, R. Waltrip: Desipramine-associated hepatitis. J. Clin. Psychopharmacol. 3 (1983) 243-246
12. Prudent, A., B. Marchetti, D. Pignol, G. Lacroix, G. Bouckson, M. Legre: Acute benign hepatitis probably due to maprotiline. Gastroenterol. Clin. Biol. 12 (1988) 80
13. Rasmussen, S., J. H. Quedens: Possible cross hepatotoxicity between tricyclic and tetracyclic antidepressive agents. Ugeskr. Laeger 153 (1991) 3020-3022
14. Shaefer, M. S., A. L. Edmunds, R. S. Markin, R. P. Wood, T. J. Pillen, B. W. Shaw Jr.: Hepatic failure associated with imipramine therapy. Pharmacotherapy 10 (1990) 66-69
15. Short, M. H., J. M. Burns, M. E. Harris: Cholestatic jaundice during imipramine therapy. J. A. M. A. 206 (1968) 1791-1792
16. Stricker, B. H. C. H., P. Spoelstra: Drug-induced hepatic injury. Elsevier, New York (1985)
17. van Vliet, A. C., M. Frenkel, J. H. Wilson: Acute liver necrosis after treatment with opipramol. Ned. Tijdschr. Geneeskd. 121 (1977) 1325-1327
18. Weaver, G. A., D. Pavlinac, J. S. Davis: Hepatic sensitivity to imipramine. Am. J. Dig. Dis. 22 (1977) 551-553
19. Weinstein, R. P., J. Y. Gosselin: Case report of hepatotoxicity associated with maprotiline. Can. J. Psychiatry 33 (1988) 233-234
20. Yon, J., S. Anuras: Hepatitis caused by amitriptyline therapy. J. A. M. A. 232 (1975) 833-834
21. Zimmermann, H. J.: Drug-induced liver disease. Drugs 16 (1978) 25-45